Legal Opinion
Gardley-Starks v. Pfizer, Inc.
District Court, N.D. Mississippi
Decided January 10, 2013No. Civil Action No. 4:10-CV-099-SA-JMVPublishedCited by 8 opinions
1Opinion of the Court
MEMORANDUM OPINION
SHARION AYCOCK, District Judge.
In this diversity action, Plaintiff Lirlene Gardley-Starks asserts numerous causes of action under Mississippi law, arguing that her ingestion of the prescription drug metoclopramide caused her to develop a neurological disorder known as tardive dyskinesia. Before the Court is a Motion for Summary Judgment [81] filed by Defendant Schwarz Pharma, Inc., and a Motion for Partial Summary Judgment [83]1 filed by Defendants Pfizer, Inc., and Wyeth Inc. (collectively, the “Brand Defendants”). Also before the Court is a Joint Motion to Dismiss for…
2Cases cited44 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Cipollone v. Liggett Group, Inc.Supreme Court of the United States · 1992
- Martin K. Eby Construction Company, Inc. v. Dallas Area Rapid TransitCourt of Appeals for the Fifth Circuit · 2004
39 more not listed; retrieve them via the Exa API.
3Cited by8 opinions
- Yanise Germain v. Teva Pharmaceuticals, USA, IncCourt of Appeals for the Sixth Circuit · 2014
- Andrea Guarino v. Wyeth, LLCCourt of Appeals for the Eleventh Circuit · 2013
- Chatman v. Pfizer, Inc.District Court, S.D. Mississippi · 2013
- Kent Holifield v. City Salvage, Inc.Court of Appeals of Mississippi · 2017
- Dickens v. Autozone, Inc.District Court, S.D. Mississippi · 2019
3 more not listed; retrieve them via the Exa API.